1. Home
  2. ENVB vs XXII Comparison

ENVB vs XXII Comparison

Compare ENVB & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$2.03

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$3.63

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVB
XXII
Founded
1994
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.3M
IPO Year
2000
2011

Fundamental Metrics

Financial Performance
Metric
ENVB
XXII
Price
$2.03
$3.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
251.9K
28.1K
Earning Date
01-01-0001
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,914,675.00
$25,832,530.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$79.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.67
52 Week High
$13.25
$11.37

Technical Indicators

Market Signals
Indicator
ENVB
XXII
Relative Strength Index (RSI) 38.31 40.77
Support Level $1.96 $3.61
Resistance Level $4.29 $6.86
Average True Range (ATR) 0.13 0.33
MACD 0.05 -0.13
Stochastic Oscillator 30.60 6.64

Price Performance

Historical Comparison
ENVB
XXII

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: